ALERIS CORPORATION (NYSE:ARS) Files An 8-K Entry into a Material Definitive Agreement

Item1.01. Entry into a Material Definitive Agreement.

On February8, 2017, Aleris International, Inc. (the Company), and
certain of its subsidiaries entered into a second amendment (the
Second Amendment) to that certain Credit Agreement, dated June15,
2015, by and among the Company, the other borrowers and loan
parties party thereto, the lenders party thereto, JPMorgan Chase
Bank, N.A., as administrative agent, J.P. Morgan Europe Limited,
as European Agent, Bank of America, N.A., as syndication agent,
and Barclays Bank PLC and Deutsche Bank Securities Inc., as
syndication agents (as renewed, extended, modified, amended,
supplemented or restated through the date of amendment, the 2015
ABL Facility).

The Second Amendment modifies certain provisions of the 2015 ABL
Facility to, among other things, permit the issuance of an
additional $200million aggregate principal amount of 9.500%
senior secured notes due 2021, as described below.

Certain of the lenders and their affiliates perform and have
performed commercial and investment banking and advisory services
for the Company from time to time for which they receive and have
received customary fees and expenses. The lenders and their
affiliates may, from time to time, engage in transactions with
and perform services for the Company in the ordinary course of
their business for which they will receive fees and expenses.

The foregoing description of the Second Amendment does not
propose to be complete and is qualified in its entirety by
reference to the full text of the Second Amendment, which will be
filed as an exhibit to the Companys next periodic report.

Item7.01. Regulation FD Disclosure.

On February9, 2017, the Company issued a press release announcing
that it intends to offer (the Private Offering) an additional
$200million aggregate principal amount of 9.500% senior secured
notes due 2021 (the Notes), subject to market and other
conditions, in a private offering that is exempt from the
registration requirements of the Securities Act of 1933, as
amended. The Notes will be issued under the same indenture as the
9.500% senior secured notes due 2021 (the Initial Notes) issued
by the Company on April4, 2016. The Notes together with the
Initial Notes will be treated as a single series of debt
securities for all purposes under the indenture, including,
without limitation, waivers, amendments, redemptions and offers
to purchase. The Company intends to use the net proceeds from the
Private Offering for general corporate purposes, which may
include working capital and/or capital expenditures. A copy of
the press release announcing the Companys intention to offer the
Notes is set forth as Exhibit 99.1 hereto and incorporated by
reference herein.

Portions of the summary section and other information from a
preliminary offering circular prepared by the Company in
connection with the Private Offering of Notes are attached as
Exhibit 99.2 hereto and incorporated by reference herein. The
information contained in Exhibit 99.2 should be considered in the
context of the Companys filings with the Securities and Exchange
Commission and other public announcements that the Company may
make by press release or otherwise from time to time. Such
information speaks as of the date of this Current Report on Form
8-K. The Company specifically disclaims any obligation to update
the attached materials in the future, except as may be required
by law.

The information in Item 7.01 on this Current Report on Form 8-K
and Exhibits 99.1 and 99.2 attached hereto are being furnished to
the Securities and Exchange Commission to Item 7.01 of Form 8-K
and shall not be deemed filed for purposes of Section18 of the
Securities Exchange Act of 1934, as amended (the Exchange Act),
or otherwise subject to the liabilities of that Section, nor
shall any such information or exhibits be deemed incorporated by
reference in any filing under the Exchange Act or the Securities
Act of 1933, as amended.

The information furnished in this Form 8-K to Item 7.01, including
the information contained in Exhibits 99.1 and 99.2, is neither
an offer to sell nor a solicitation of an offer to buy any of the
Notes in the Private Offering.